BeyondSpring reports phase 2 trial results for lung cancer treatment

June 2, 2026 7:01 AM

BeyondSpring Inc. (NASDAQ: BYSI) reported updated results from a phase 2 clinical trial evaluating a combination therapy for patients with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found